Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-14

Clinical Trial Update: Cost-utility and Biological Underpinnings of MBSR in Fibromyalgia Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 trial investigating cost-utility and biological underpinnings of Mindfulness-Based Stress Reduction (MBSR) for fibromyalgia syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fundació Sant Joan de Déu | Conditions: Fibromyalgia Syndrome | Phase 3 | Status: COMPLETED